ZFP119 inhibitors are a class of compounds specifically designed to target zinc finger protein 119 (ZFP119), a transcription factor that plays a key role in regulating gene expression by binding to specific DNA sequences. ZFP119, like other zinc finger proteins, contains zinc finger motifs, which are structural domains that allow it to interact with DNA in a highly specific manner. These zinc finger motifs are stabilized by the coordination of zinc ions, which are essential for maintaining the protein's three-dimensional conformation. ZFP119 is involved in modulating the transcription of a variety of genes, influencing important cellular processes. Inhibitors of ZFP119 act by disrupting its ability to bind DNA, either by destabilizing the zinc finger motifs or by preventing the protein from recognizing and binding to its target DNA sequences, ultimately leading to changes in gene regulation.
The mechanisms by which ZFP119 inhibitors exert their effects can vary depending on the chemical properties of the compounds. One common mechanism involves chelating the zinc ions required for the structural stability of the zinc finger domains. By binding to these zinc ions, the inhibitors cause the zinc finger motifs to lose their proper conformation, rendering ZFP119 unable to bind to DNA. This disruption prevents ZFP119 from controlling the transcription of its target genes, thereby affecting cellular pathways that rely on its regulatory activity. Other inhibitors may block protein-protein interactions that are critical for ZFP119's function in forming transcriptional complexes. By inhibiting these interactions, ZFP119 inhibitors further impair the protein's role in gene regulation. The study of ZFP119 inhibitors provides valuable insights into the broader role of zinc finger proteins in gene regulation, contributing to a deeper understanding of transcriptional control and its impact on cellular processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Actinomycin D inhibits ZNF119a expression by binding to DNA, preventing RNA polymerase from elongating. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $60.00 $185.00 $365.00 | 64 | |
Resveratrol inhibits ZNF119a expression through its ability to modulate various signaling pathways. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
Curcumin inhibits ZNF119a by affecting multiple pathways involved in gene expression and protein synthesis. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $32.00 $170.00 $385.00 | 63 | |
Etoposide inhibits ZNF119a expression by interfering with topoisomerase II, leading to DNA damage and repair. | ||||||
Ellagic Acid, Dihydrate | 476-66-4 | sc-202598 sc-202598A sc-202598B sc-202598C | 500 mg 5 g 25 g 100 g | $57.00 $93.00 $240.00 $713.00 | 8 | |
Ellagic acid may inhibit ZNF119a by modulating transcription factors and impacting gene expression pathways. | ||||||
Berberine | 2086-83-1 | sc-507337 | 250 mg | $90.00 | 1 | |
Berberine inhibits ZNF119a through its ability to modulate gene expression and interfere with DNA transcription. | ||||||
Flavopiridol | 146426-40-6 | sc-202157 sc-202157A | 5 mg 25 mg | $78.00 $254.00 | 41 | |
Flavopiridol inhibits ZNF119a by targeting cyclin-dependent kinases, which are involved in gene transcription. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $57.00 $182.00 $92.00 | 21 | |
Camptothecin inhibits ZNF119a expression by trapping topoisomerase I-DNA complexes, leading to DNA damage. | ||||||
Ellipticine | 519-23-3 | sc-200878 sc-200878A | 10 mg 50 mg | $142.00 $558.00 | 4 | |
Ellipticine inhibits ZNF119a expression by intercalating DNA and affecting the function of DNA topoisomerases. | ||||||